Cidara Therapeutics
CDTX
CDTX
49 hedge funds and large institutions have $42.5M invested in Cidara Therapeutics in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 19 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0.3% less ownership
Funds ownership: 3.18% → 2.89% (-0.3%)
58% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 19
Holders
49
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$267K | |
| 2 | +$217K | |
| 3 | +$213K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$79.5K |
| 5 |
Bank of New York Mellon
New York
|
+$53K |
Top Sellers
| 1 | -$3.16M | |
| 2 | -$530K | |
| 3 | -$356K | |
| 4 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$330K |
| 5 |
JPMorgan Chase & Co
New York
|
-$192K |